Nomura Asset Management CO LTD Vaxcyte, Inc. Transaction History
Nomura Asset Management CO LTD
- $31.8 Billion
- Q3 2024
A detailed history of Nomura Asset Management CO LTD transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 806 shares of PCVX stock, worth $70,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
806
Previous 0
Infinity%
Holding current value
$70,186
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PCVX
# of Institutions
353Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$996 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$951 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$866 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$757 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$427 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.17B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...